Petros Pharmaceuticals
PTPI
C$0.03828
Share price
-7.33%
Change (1 day)
-93.26%
Change (1 year)
Categories
Revenue for Petros Pharmaceuticals (PTPI)
Revenue in 2025 (TTM): C$5.11 Million
According to Petros Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is C$5.12 Million. In 2024 the company made a revenue of C$5.34 Million a decrease over the revenue in the year 2023 that were of C$7.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Petros Pharmaceuticals from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | C$5.11 M | -4.23% |
| 2024 | C$5.34 M | -30.82% |
| 2023 | C$7.72 M | -5.02% |
| 2022 | C$8.13 M | -18.32% |
| 2021 | C$9.95 M | -18.33% |
| 2020 | C$12.18 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | C$0.19 B | 3,695.00% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |